New research indicates that for women with advanced epithelial ovarian cancer whose cancer has relapsed after surgery, a second surgery is worth considering. The population-based registry study confirms the results suggested by a recent randomized trial.

In the Acta Obstetricia et Gynecologica Scandinavica study, secondary surgery delayed a new recurrence for 2 years and resulted in at least 6 years median overall survival.

Source: Read Full Article